NetworkNewsBreaks – Brain Scientific Inc. (BRSF)
Post# of 129
(Total Views: 215)
Posted On: 02/17/2021 3:03:43 PM
NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Signs Memorandum of Understanding with Ehave, Inc. (EHVVF) to Map Brain Response
Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company with two FDA-cleared products, has entered into a memorandum of understanding (“MoU”) with Ehave, Inc. (OTC: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors. The agreement calls for the two companies to work together to map brain response to psychedelics being administered as a treatment for chronic pain, depressions (both major and persistent), post-traumatic stress disorder, bipolar disorder, general anxiety, ADHD and schizophrenia. The two companies will also collaborate in the development of neural net algorithms for the mental-health sector. BRSF’s e-tattoo technology will be used to provide continuous monitoring in the studies. According to the announcement, the MoU calls for Ehave to integrate Brain Scientific’s NeuroCap and NeuroEEG to obtain data from patients in real time; Ehave may also use the two devices in clinical settings with Ehave’s partner healthcare providers in order to gather data about the electrophysiological changes in brain pre-, mid- and post-psychedelic drug administration. Initial plans indicate the collection research could start in Australia and then be implemented in other areas. The research and data will be jointly owned by both Ehave and Brain Scientific. “Our current EEG device is about the size of a stamp,” said Brain Scientific chairman Boris Goldstein in the press release. “By shrinking the technology, the system allows for continuous measurement during a person’s normal activities, while providing a non-intrusive way to monitor various disorders. We believe the future of EEG testing will be centered around the ability to gather more precise data through non-invasive measures of the brain via 3D temporary imprint or implanted graphene electrodes. By utilizing graphene, which has been called a ‘wonder material of the 21st century,’ Brain Scientific believes the size of the electrodes can be thinner than a human hair and will allow brain activity monitoring with minimal distraction from everyday life.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company with two FDA-cleared products, has entered into a memorandum of understanding (“MoU”) with Ehave, Inc. (OTC: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors. The agreement calls for the two companies to work together to map brain response to psychedelics being administered as a treatment for chronic pain, depressions (both major and persistent), post-traumatic stress disorder, bipolar disorder, general anxiety, ADHD and schizophrenia. The two companies will also collaborate in the development of neural net algorithms for the mental-health sector. BRSF’s e-tattoo technology will be used to provide continuous monitoring in the studies. According to the announcement, the MoU calls for Ehave to integrate Brain Scientific’s NeuroCap and NeuroEEG to obtain data from patients in real time; Ehave may also use the two devices in clinical settings with Ehave’s partner healthcare providers in order to gather data about the electrophysiological changes in brain pre-, mid- and post-psychedelic drug administration. Initial plans indicate the collection research could start in Australia and then be implemented in other areas. The research and data will be jointly owned by both Ehave and Brain Scientific. “Our current EEG device is about the size of a stamp,” said Brain Scientific chairman Boris Goldstein in the press release. “By shrinking the technology, the system allows for continuous measurement during a person’s normal activities, while providing a non-intrusive way to monitor various disorders. We believe the future of EEG testing will be centered around the ability to gather more precise data through non-invasive measures of the brain via 3D temporary imprint or implanted graphene electrodes. By utilizing graphene, which has been called a ‘wonder material of the 21st century,’ Brain Scientific believes the size of the electrodes can be thinner than a human hair and will allow brain activity monitoring with minimal distraction from everyday life.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)